307
Views
18
CrossRef citations to date
0
Altmetric
Drug Profile

Desvenlafaxine succinate for major depressive disorder: a critical review of the evidence

&
Pages 1787-1797 | Published online: 09 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Gaia Sampogna, Filippo Caraci, Claudia Carmassi, Bernardo Dell’Osso, Silvia Ferrari, Giovanni Martinotti, Gabriele Sani, Gianluca Serafini, Maria Salvina Signorelli & Andrea Fiorillo. (2023) Efficacy and tolerability of desvenlafaxine in the real-world treatment of patients with major depression: a narrative review and an expert opinion paper. Expert Opinion on Pharmacotherapy 24:14, pages 1511-1525.
Read now
Chi-Un Pae. (2011) Desvenlafaxine in the treatment of major depressive disorder. Expert Opinion on Pharmacotherapy 12:18, pages 2923-2928.
Read now
Ho-Jun Seo, Manmohandeep Singh Sohi, Ashwin A. Patkar, Prakash S. Masand & Chi-Un Pae. (2010) Desvenlafaxine Succinate: A Newer Antidepressant for the Treatment of Depression and Somatic Symptoms. Postgraduate Medicine 122:1, pages 125-138.
Read now

Articles from other publishers (15)

Sungwon Roh, Kang Soo Lee, Songhwa Choi & Jae-Min Kim. (2022) Safety and Effectiveness of Desvenlafaxine in Korean Patients with Major Depressive Disorder: A 6-month Postmarketing Surveillance Study. Clinical Psychopharmacology and Neuroscience 20:3, pages 548-559.
Crossref
Shiwei Yang, Shiyun Chen, Cheng Wang, Shibo Zhang, Shuaifei Li, Xinsong Yuan, Fuyun Peng & Yong He. (2022) Advances in Research at Synthesis Process Optimization and Quality Standard Improvement of O-desmethylvenlafaxine Succinate. Frontiers in Chemistry 10.
Crossref
Narcís Cardoner, Antoni Sicras-Mainar, Javier Rejas & Beatriz Armada. (2021) Adherence to Desvenlafaxine Versus Usual Care and Its Impact on Health Outcomes: A Comparative Real-world Clinical Study. Clinical Drug Investigation 41:12, pages 1055-1066.
Crossref
Jie Jack Li. 2020. Medicinal Chemistry for Practitioners. Medicinal Chemistry for Practitioners 133 224 .
Alan F. Schatzberg & Charles DeBattista. 2019. Schatzberg’s Manual of Psychopharmacology. Schatzberg’s Manual of Psychopharmacology.
Alan F. Schatzberg & Charles DeBattista. 2019. Schatzberg’s Manual of Psychopharmacology. Schatzberg’s Manual of Psychopharmacology.
A. S. Bansode, V. D. Shelke & S. S. Gaikwad. (2017) RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR ESTIMATION OF DESVENLAFAXINE SUCCINATE BULK DRUG IN ARTIFICIAL URINE. INDIAN DRUGS 54:05, pages 37-40.
Crossref
Belén Arranz. (2014) Duloxetina y trastorno de ansiedad generalizada, una buena asociación. Psiquiatría Biológica 21:1, pages 3-8.
Crossref
Patrícia da Fonseca & Pierina Sueli Bonato. (2013) Hollow-fiber liquid-phase microextraction and chiral LC–MS/MS analysis of venlafaxine and its metabolites in plasma. Bioanalysis 5:6, pages 721-730.
Crossref
Narcís Cardoner Álvarez. (2013) Desvenlafaxina, un nuevo IRSN para el tratamiento de la depresión mayor: Revisión de la literatura. Psiquiatría Biológica 20:1-2, pages 2-7.
Crossref
Bernardo Dell’Osso, M. Carlotta Palazzo, Lucio Oldani & A. Carlo Altamura. (2011) The Noradrenergic Action in Antidepressant Treatments: Pharmacological and Clinical Aspects. CNS Neuroscience & Therapeutics 17:6, pages 723-732.
Crossref
Magid Abou-Gharbia & Wayne E. ChildersJr.Jr.. 2010. Analogue-Based Drug Discovery II. Analogue-Based Drug Discovery II 507 524 .
David F. Archer. (2010) Desvenlafaxine: A therapeutic option for treatment of menopausal hot flashes. Maturitas 66:1, pages 1-2.
Crossref
Antolin C. TrinidadBenjamin Bregman. (2010) Pharmacotherapy of Major Depressive Disorder: Focus on Desvenlafaxine Succinate. Clinical Medicine Insights: Therapeutics 2, pages CMT.S74.
Crossref
Patrícia da Fonseca & Pierina Sueli Bonato. (2009) Chiral HPLC analysis of venlafaxine metabolites in rat liver microsomal preparations after LPME extraction and application to an in vitro biotransformation study. Analytical and Bioanalytical Chemistry 396:2, pages 817-824.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.